Last reviewed · How we verify

NCT07343011

Conjunctival Transpositional Surgery for Primary Pterygium

Recruiting now NA Last updated 15 January 2026
What this trial tests

NA trial testing Conjunctival Transpositional Pterygium Surgery in Pterygium of the Conjunctiva and Cornea in 70 participants. Currently enrolling.

Timeline
21 May 2025
Primary endpoint
1 May 2026
1 January 2027

Quick facts

Lead sponsorZahedan University of Medical Sciences
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment70
Start date21 May 2025
Primary completion1 May 2026
Estimated completion1 January 2027
Sites1 location across Iran

Drugs / interventions tested

Conditions studied

Sponsor

Zahedan University of Medical Sciences

Who can join

18 and older, any sex, with Pterygium of the Conjunctiva and Cornea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective single-arm interventional study evaluates the recurrence rate and functional outcomes following conjunctival transpositional pterygium surgery without bare sclera formation. The technique involves mobilization and transposition of the pterygium tissue while preserving Tenon's layer and avoiding adjunctive therapies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Zahedan University of Medical Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07343011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing